AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 15725087
Drug: Pre-emptive immunotherapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pre-emptive immunotherapy
Trial: 6501905
Drug: Purified trivalent
RxNorm normalized name: RAYON,PURIFIED
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Purified trivalent sub‐unit influenza vaccine
Trial: 6501905
Drug: 14‐valent pneumococcal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 14‐valent pneumococcal vaccine
Trial: 30281866
Drug: HDM sublingual
RxNorm normalized name: ODACTRA 12 SQ-HDM Sublingual Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: HDM sublingual tablets (300 index of reactivity) once daily for 52 weeks
Trial: 30143003
Drug: Clinical medication
RxNorm normalized name: DuoCare Clinical
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clinical medication review (CMR) focused on patients' preferences, personal goals, and health-related complaints.
Trial: 30143003
Drug: Secondary outcomes
RxNorm normalized name: Secondary potassium phosphate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Secondary outcomes include healthcare utilisation, number and type of drug changes, number and type of health-related goals, scores on goal attainment scale (GAS), and number and type of drug-related problems (DRPs) and interventions.
Trial: 26414074
Drug: Injection speed
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Injection speed of 0.3 ml/s (15 seconds)
Trial: 26414074
Drug: Injection speed
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Injection speed of 0.15 ml/s (30 seconds)
Trial: 26414074
Drug: Injection speed
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Injection speed of 0.1 ml/s (45 seconds)
Trial: 24899160
Drug: 6 mg/d
RxNorm normalized name: EMSAM 6 MG/Day 24HR Transdermal System
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 6 mg/d lutein (low-dose)
Trial: 24899160
Drug: 12 mg/d
RxNorm normalized name: EMSAM 12 MG/Day 24HR Transdermal System
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 12 mg/d lutein (high-dose)
Trial: 24899160
Drug: 0 mg/d
RxNorm normalized name: Arixtra 10 mg/dose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0 mg/d lutein (placebo)
Trial: 22992291
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (73 patients) that continued treatment based on recorded PROMs and clinical assessment.
Trial: 15452011
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of strategies
Trial: 9186385
Drug: DTP-IPV vaccine
RxNorm normalized name: poliovirus vaccine inactivated, type 1 (Mahoney)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: DTP-IPV vaccine alone (n = 43)
Trial: 9186385
Drug: DTP-IPV vaccine
RxNorm normalized name: poliovirus vaccine inactivated, type 1 (Mahoney)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: DTP-IPV vaccine with PVRV (n = 41)
Trial: 8233146
Drug: Oral laxatives
RxNorm normalized name: Pedia-Lax Oral Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral laxatives
Trial: 8233146
Drug: Conditional rectal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conditional rectal cathartics
Trial: 3887636
Drug: DHE‐Heparin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: DHE‐Heparin
Trial: 15293865
Drug: AS 195
RxNorm normalized name: levodopa 195 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: AS 195 360mg once daily for 6 weeks
Trial: 9683395
Drug: L-tryptophan (30
FDA approved: no
EMA approved: no
PMDA approved: no
Description: L-tryptophan (30 mg/kg)
Trial: 7832179
Drug: Cocaine use
RxNorm normalized name: Cocaine
DrugBank: Cocaine (DB00907)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cocaine use during methadone maintenance (35 mg)
Trial: 7832179
Drug: Cocaine use
RxNorm normalized name: Cocaine
DrugBank: Cocaine (DB00907)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cocaine use during buprenorphine maintenance (2 mg)
Trial: 7832179
Drug: Cocaine use
RxNorm normalized name: Cocaine
DrugBank: Cocaine (DB00907)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cocaine use during buprenorphine maintenance (6 mg)
Trial: 7832179
Drug: Cocaine use
RxNorm normalized name: Cocaine
DrugBank: Cocaine (DB00907)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cocaine use during methadone maintenance (120 mg)
Trial: 7832179
Drug: Methadone maintenance
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Methadone maintenance (35 mg)
Trial: 7832179
Drug: Buprenorphine maintenance
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Buprenorphine maintenance (2 mg)
Trial: 7832179
Drug: Buprenorphine maintenance
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Buprenorphine maintenance (6 mg)
Trial: 7832179
Drug: Methadone maintenance
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Methadone maintenance (120 mg)
Trial: 2979249
Drug: Oral rehydration
RxNorm normalized name: Oral rehydration salt formulations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral rehydration solution (ORS) containing bicarbonate
Trial: 2979249
Drug: Oral rehydration
RxNorm normalized name: Oral rehydration salt formulations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral rehydration solution (ORS) without bicarbonate (chloride ions instead)
Trial: 24962607
Drug: Oxytocin nasal
RxNorm normalized name: oxytocin Nasal Spray
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oxytocin nasal spray (24 International Units, twice-daily for 6 weeks) combined with social cognition training (2 × 1 hour weekly sessions for 6 weeks)
Trial: 24962607
Drug: Placebo nasal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo nasal spray combined with social cognition training (2 × 1 hour weekly sessions for 6 weeks)
Trial: 24962607
Drug: Oxytocin nasal
RxNorm normalized name: oxytocin Nasal Spray
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oxytocin nasal spray (24 International Units, twice-daily for 6 weeks)
Trial: 21857390
Drug: Iron supplementation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Iron supplementation (0, 1, or 2 mg iron/kg/d) from 6 weeks to 6 months of age
Trial: 21857390
Drug: Iron supplementation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Iron supplementation (2 mg group)
Trial: 18827732
Drug: 700 microg
RxNorm normalized name: Dexamethasone 700 microgram prolonged-release ocular implant
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 700 microg dexamethasone drug delivery system via a 22-gauge applicator insertion (n = 20)
Trial: 18827732
Drug: 700 microg
RxNorm normalized name: Dexamethasone 700 microgram prolonged-release ocular implant
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 700 microg dexamethasone drug delivery system via a pars plana incisional placement (n = 10)
Trial: 11120722
Drug: Oestrogen alone,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oestrogen alone, oral or transdermal
Trial: 11120722
Drug: Implant (oestrogen
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Implant (oestrogen and testosterone)
Trial: 9124831
Drug: Once-weekly azithromycin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Once-weekly azithromycin (10 mg/kg)
Trial: 9124831
Drug: Once-weekly azithromycin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Once-weekly azithromycin (5 mg/kg)
Trial: 9124831
Drug: Once-daily amoxicillin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Once-daily amoxicillin (20 mg/kg)
Trial: 9124831
Drug: Both azithromycin
RxNorm normalized name: Azithromycin
DrugBank: Azithromycin (DB00207)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Both azithromycin and amoxicillin groups
Trial: 1433775
Drug: 20 g/day
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 g/day arginine hydrochloride
Trial: 1433775
Drug: Mixed amino
RxNorm normalized name: Humalog Mix
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mixed amino acid solution (Travasol)
Trial: 20610202
Drug: Chlorhexidine gluconate
RxNorm normalized name: Chlorhexidine Gluconate
DrugBank: Chlorhexidine (DB00878)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Chlorhexidine gluconate (4%) scrub followed by alcohol impregnated with iodine (1%) solution
Trial: 26048134
Drug: Olaparib 400
RxNorm normalized name: Olaparib
DrugBank: Olaparib (DB09074)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Olaparib 400 mg (8 × 50 mg capsules) after a standard meal
Trial: 26048134
Drug: Olaparib 400
RxNorm normalized name: Olaparib
DrugBank: Olaparib (DB09074)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Olaparib 400 mg (8 × 50 mg capsules) after a high‐fat meal
Trial: 26048134
Drug: Olaparib 400
RxNorm normalized name: Olaparib
DrugBank: Olaparib (DB09074)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Olaparib 400 mg (8 × 50 mg capsules) in the fed state (standard meal)
Trial: 26048134
Drug: Olaparib 400
RxNorm normalized name: Olaparib
DrugBank: Olaparib (DB09074)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Olaparib 400 mg (8 × 50 mg capsules) in the fed state (high‐fat meal)
Trial: 23528399
Drug: Balneopeloid therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Balneopeloid therapy with irrigation of high mineralized natural water and application of sapropel mud
Trial: 21716273
Drug: Verapamil (various
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Verapamil (various doses)
Trial: 21716273
Drug: Quinidine (various
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Quinidine (various doses)
Trial: 15596605
Drug: Donepezil 5
RxNorm normalized name: donepezil 5 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Donepezil 5 mg/d for 6 weeks, then 10 mg/d
Trial: 9729054
Drug: Mometasone furoate
RxNorm normalized name: Mometasone Furoate
DrugBank: Mometasone furoate (DB14512)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Mometasone furoate (topical corticosteroid)
Trial: 2500248
Drug: 20-cm2 nitroglycerin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20-cm2 nitroglycerin adhesive transdermal patch applied for a single 24-hour period (q24hr)
Trial: 2500248
Drug: 2% nitroglycerin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2% nitroglycerin ointment applied over a 50-cm2 area every eight hours (q8hr)
Trial: 528095
Drug: Phenobarbital tablets,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Phenobarbital tablets, USP, 100 mg (7 different brands)
Trial: 528095
Drug: Phenobarbital tablets,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Phenobarbital tablets, USP, 100 mg (Preparations A and E)
Trial: 528095
Drug: Phenobarbital tablets,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Phenobarbital tablets, USP, 100 mg
Trial: 23994951
Drug: Metronidazole 750
RxNorm normalized name: metronidazole 750 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metronidazole 750 mg ± miconazole
Trial: 23994951
Drug: Metronidazole 500
RxNorm normalized name: metronidazole 500 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metronidazole 500 mg ± miconazole
Trial: 19246922
Drug: Low-dose aspirin
RxNorm normalized name: low-dose aspirin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low-dose aspirin for 14 days
Trial: 19246922
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (no drugs for 14 days)
Trial: 17209663
Drug: Serotonergic drugs
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Serotonergic drugs (SSRIs, dexfenfluramine, 5‐HT2C receptor agonists)
Trial: 17209663
Drug: Sibutramine, dexfenfluramine,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sibutramine, dexfenfluramine, fluoxetine, chlorophenylpiperazine (mCPP)
Trial: 17209663
Drug: 5‐HT2C receptor
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5‐HT2C receptor selective agonists (lorcaserin)
Trial: 17209663
Drug: 5‐HT6 receptor
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5‐HT6 receptor antagonists (PRX‐07034, BVT74316)
Trial: 1303863
Drug: 4% Sodium
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 4% Sodium Cromoglycate used twice daily
Trial: 1303863
Drug: 2% Sodium
RxNorm normalized name: Dextrose 5% and 0.2% Sodium Chloride
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2% Sodium Cromoglycate used four times daily
Trial: 3856458
Drug: Fenfluramine (60
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fenfluramine (60 mg po)
Trial: 25114584
Drug: Pregabalin (150-600
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pregabalin (150-600 mg/day)
Trial: 20029243
Drug: Zaltoprofen 160
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Zaltoprofen 160 mg
Trial: 21430410
Drug: Loxoprofen 60
RxNorm normalized name: loxoprofen 60 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Loxoprofen 60 mg
Trial: 11317660
Drug: Inhaled insulin
RxNorm normalized name: insulin, regular, human Inhalation Powder [Afrezza]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhaled insulin (AERx iDMS) at dosages of 0.3, 0.6, 1.2, and 1.8 U/kg body weight
Trial: 11317660
Drug: Subcutaneous insulin
RxNorm normalized name: subcutaneous insulin pump
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Subcutaneous insulin (0.12 U/kg body weight)
Trial: 19317821
Drug: Inhaled insulin
RxNorm normalized name: insulin, regular, human Inhalation Powder [Afrezza]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhaled insulin (AERx iDMS)
Trial: 19207292
Drug: Orlistat 120
RxNorm normalized name: orlistat 120 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Orlistat 120 mg tid
Trial: 8236144
Drug: Diltiazem (120,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diltiazem (120, 240, or 360 mg/day)
Trial: 7564036
Drug: Aspirin (81
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aspirin (81 mg/day)
Trial: 8236144
Drug: Aspirin plus
RxNorm normalized name: Aspirin Plus Antacid Extra Strength
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aspirin plus Diltiazem (81 mg/day + diltiazem)
Trial: 28793958
Drug: Amisulpride (200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amisulpride (200 mg)
Trial: 28793958
Drug: Conventional formulation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional formulation of amisulpride
Trial: 20728093
Drug: High dose
RxNorm normalized name: INFLUENZA VACCINE HIGH DOSE 0.5ML SYR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High dose intensity groups
Trial: 18922570
Drug: Rofecoxib (25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rofecoxib (25 mg)
Trial: 11391165
Drug: 800-mg amprenavir
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 800-mg amprenavir (APV) combined with 800-mg indinavir (IDV)
Trial: 11391165
Drug: 800-mg amprenavir
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 800-mg amprenavir (APV) combined with 750-mg nelfinavir (NFV)
Trial: 11391165
Drug: 800-mg amprenavir
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 800-mg amprenavir (APV) combined with 800-mg saquinavir-Soft Gel Capsule (SGV-SGC)
Trial: 11391165
Drug: APV given
RxNorm normalized name: FOS-APV
DrugBank: Fosamprenavir (DB01319)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: APV given alone for 3 weeks and then with 150-mg lamivudine (3TC) and 300-mg zidovudine (ZDV)
Trial: 10087435
Drug: SK+heparin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: SK+heparin
Trial: 10087435
Drug: rt-PA+heparin
RxNorm normalized name: rt-PA
DrugBank: Alteplase (DB00009)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: rt-PA+heparin
Trial: 10087435
Drug: High-dose intravenous
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose intravenous heparin
Trial: 29278871
Drug: Traditional dysphagia
RxNorm normalized name: sodium fluoride
DrugBank: Sodium fluoride (DB09325)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Traditional dysphagia therapy (TDT) + surface neuromuscular electrical stimulation (sNMES) in treatment group A (TGA)
Trial: 29278871
Drug: Traditional dysphagia
RxNorm normalized name: sodium fluoride
DrugBank: Sodium fluoride (DB09325)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Traditional dysphagia therapy (TDT) + surface neuromuscular electrical stimulation (sNMES) in treatment group B (TGB)
Trial: 29278871
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (traditional dysphagia therapy only)
Trial: 23254482
Drug: G-Cog power
FDA approved: no
EMA approved: no
PMDA approved: no
Description: G-Cog power meter
Trial: 18727842
Drug: 21 mg/24-h
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 21 mg/24-h nicotine patch
Trial: 18727842
Drug: 15 mg/16-h
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 15 mg/16-h nicotine patch
Trial: 8761582
Drug: 3-day Quinimax
RxNorm normalized name: quinidine sulfate Extended Release Oral Tablet [Quinidex]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 3-day Quinimax treatment (25 mg/kg daily in 3 doses)
Trial: 8761582
Drug: 7-day Quinimax
RxNorm normalized name: quinidine sulfate Extended Release Oral Tablet [Quinidex]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 7-day Quinimax treatment (25 mg/kg daily in 3 doses)
Trial: 8761582
Drug: 3-day Quinimax
RxNorm normalized name: quinidine sulfate Extended Release Oral Tablet [Quinidex]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 3-day Quinimax treatment
Trial: 2328746
Drug: Cimetidine 400
RxNorm normalized name: cimetidine 400 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cimetidine 400 mg b.d. for one week
Trial: 2328746
Drug: Ranitidine 150
RxNorm normalized name: ranitidine 150 MG
DrugBank: Ranitidine (DB00863)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ranitidine 150 mg b.d. for one week
Trial: 28652290
Drug: Duloxetine (30
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Duloxetine (30 mg for 2 weeks, then 60 mg for 4 weeks)
Trial: 15113316
Drug: Gatifloxacin 400
RxNorm normalized name: gatifloxacin 400 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gatifloxacin 400 mg once-daily for 5-14 days
Trial: 15113316
Drug: Clarithromycin 500
RxNorm normalized name: clarithromycin 500 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clarithromycin 500 mg twice-daily for 5-14 days
Trial: 25322274
Drug: 1,000 mg
RxNorm normalized name: bran 1,000 mg ORAL WAFER
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1,000 mg Resveratrol (RSV(high))
Trial: 25322274
Drug: 150 mg
RxNorm normalized name: pectin 150 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 150 mg Resveratrol (RSV(low))
Trial: 1589237
Drug: Aspirin (1200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aspirin (1200 mg in effervescent solution)
Trial: 1589237
Drug: Placebo (identically
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (identically tasting solution without aspirin)
Trial: 12957419
Drug: Aspirin and
RxNorm normalized name: Aspirin and Caffeine Tablets
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aspirin and Placebo
Trial: 3755052
Drug: Cimetidine (300
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cimetidine (300 mg oral dose)
Trial: 27085322
Drug: Orofacial myofunctional
RxNorm normalized name: stannous fluoride
DrugBank: Stannous fluoride (DB11092)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Orofacial myofunctional therapy (OMT) + OM exercises
Trial: 23991748
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group with antibiotic susceptibility testing after MALDI‐TOF MS identification
Trial: 20610466
Drug: Patients' beliefs
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Patients' beliefs about hypertension and treatment
Trial: 8857989
Drug: Magnesium sulfate
RxNorm normalized name: Magnesium Sulfate
DrugBank: Magnesium (DB14513)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Magnesium sulfate (15 mmol/L) in the cardioplegic solution (group 1)
Trial: 8857989
Drug: No magnesium
RxNorm normalized name: DPBS 1X, NO CALCIUM, NO MAGNESIUM
DrugBank: Nitric Oxide (DB00435)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: No magnesium sulfate in the cardioplegic solution (group 2)
Trial: 1320540
Drug: Candoxatril (10-200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Candoxatril (10-200 mg)
Trial: 1320540
Drug: Exogenous infusion
RxNorm normalized name: Duo Fusion
DrugBank: Magnesium hydroxide (DB09104)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Exogenous infusion of synthetic human atrial natriuretic peptide (45-90 micrograms)
Trial: 6407290
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of Zaditen and Intal
Trial: 20444958
Drug: Iron-fortified food
RxNorm normalized name: INFANT FORMULA SMA IRON FORTIFIED CONC
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Iron-fortified food product (total dose = 56 mg Fe/d), consumed twice daily during the 9-week BCT course.
Trial: 20444958
Drug: Placebo, consumed
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo, consumed twice daily during the 9-week BCT course.
Trial: 1453197
Drug: Continuous therapy
RxNorm normalized name: varenicline
DrugBank: Varenicline (DB01273)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Continuous therapy
Trial: 15712083
Drug: CD4 cell
RxNorm normalized name: lisocabtagene maraleucel
DrugBank: Lisocabtagene maraleucel (DB16582)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CD4 cell count-guided therapy
Trial: 15712083
Drug: Week-on/week-off (WOWO)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Week-on/week-off (WOWO) therapy
Trial: 15712083
Drug: All therapy
RxNorm normalized name: All Clear
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: All therapy arms
Trial: 12001824
Drug: 1% N-acetylcarnosine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1% N-acetylcarnosine (NAC) solution, topical eyedrops twice daily
Trial: 10424185
Drug: Polyester clothing
RxNorm normalized name: polyester-10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Polyester clothing with low moisture absorption and low air permeability (A)